Yutaka Otsuji Selected Research

Atherosclerotic Plaque (Atheroma)

11/2020	Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second- and third-generation drug-eluting stent implantation.
3/2018	Contribution of Poststent Irregular Protrusion to Subsequent In-Stent Neoatherosclerosis after the Second-Generation Drug-Eluting Stent Implantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutaka Otsuji Research Topics

Disease

10	Myocardial Infarction 01/2020 - 01/2003
9	Heart Failure 01/2020 - 12/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2007
7	Coronary Artery Disease (Coronary Atherosclerosis) 05/2019 - 02/2007
5	Thrombosis (Thrombus) 10/2019 - 11/2012
5	Hypertension (High Blood Pressure) 02/2018 - 08/2007
4	Chronic Renal Insufficiency 11/2021 - 05/2009
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2019 - 11/2006
4	Inflammation (Inflammations) 11/2016 - 02/2007
3	Neointima 11/2020 - 06/2007
3	Death (Near-Death Experience) 01/2020 - 11/2016
3	Acute Coronary Syndrome 01/2018 - 03/2006
3	Atherosclerosis 01/2018 - 02/2007
3	Pulmonary Hypertension 08/2015 - 11/2006
3	Hypercholesterolemia 12/2014 - 06/2010
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2014 - 11/2010
3	Vascular System Injuries 10/2011 - 03/2006
2	Hypovolemia 01/2022 - 01/2020
2	Inferior Wall Myocardial Infarction 11/2021 - 11/2013
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2021 - 09/2010
2	Ventricular Tachycardia 08/2021 - 11/2016
2	Pathologic Constriction (Stenosis) 07/2021 - 06/2013
2	Atherosclerotic Plaque (Atheroma) 11/2020 - 03/2018
2	Bradycardia 10/2020 - 01/2012
2	Heart Diseases (Heart Disease) 01/2020 - 09/2006
2	Left Ventricular Outflow Obstruction 01/2019 - 03/2006
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2017 - 06/2013
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 06/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 06/2010
2	Ischemia 08/2008 - 04/2006
2	Syncope (Fainting) 01/2007 - 11/2006
2	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2005 - 01/2003
1	Tachycardia (Tachyarrhythmias) 08/2021
1	Rupture 11/2020
1	Ventricular Fibrillation 01/2020
1	Air Embolism (Gas Embolism) 12/2019
1	Cerebral Infarction 12/2019
1	Anorexia 10/2019
1	Mitral Valve Prolapse 01/2019
1	Hemorrhage 01/2019
1	Hypertrophy 10/2018
1	Diabetes Mellitus 02/2018
1	Sudden Death 10/2017
1	Hyperemia 01/2017
1	Hyponatremia 01/2017
1	Amyloidosis 11/2016

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 11/2020 - 05/2009
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2014 - 06/2009
5	omega-Chloroacetophenone (Mace)IBA 01/2020 - 10/2013
5	oxidized low density lipoproteinIBA 02/2018 - 03/2006
5	LDL CholesterolIBA 02/2018 - 06/2010
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 06/2004
3	Adenosine Triphosphate (ATP)IBA 08/2021 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2009
3	Dobutamine FDA LinkGeneric 01/2017 - 03/2006
3	SteroidsIBA 02/2016 - 02/2009
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2009
2	cifenline (cibenzoline)IBA 01/2019 - 10/2006
2	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2018
2	Dihydrotachysterol (AT 10)IBA 01/2018 - 05/2014
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 06/2013
2	CholesterolIBA 09/2010 - 06/2010
2	Prednisolone (Predate)FDA LinkGeneric 08/2010 - 02/2009
2	Protein Isoforms (Isoforms)IBA 06/2009 - 04/2008
2	Superoxide DismutaseIBA 05/2009 - 01/2008
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2008 - 04/2008
1	enhanced green fluorescent proteinIBA 01/2022
1	Red Fluorescent ProteinIBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	Arginine Vasopressin (Argipressin)IBA 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	NeuropeptidesIBA 10/2019
1	TroponinIBA 05/2019
1	C-Reactive ProteinIBA 01/2019
1	Serum AlbuminIBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	Vitamin D FDA LinkGeneric 11/2018
1	Indicators and Reagents (Reagents)IBA 02/2018
1	Ezetimibe (Zetia)FDA Link 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	MineralocorticoidsIBA 01/2017
1	Pattern Recognition ReceptorsIBA 11/2016
1	Amyloid (Amyloid Fibrils)IBA 11/2016

Therapy/Procedure

10	Therapeutics 08/2021 - 06/2005
6	Stents 10/2019 - 11/2012
5	Percutaneous Coronary Intervention 11/2021 - 06/2015
3	Drug-Eluting Stents 07/2021 - 01/2013
3	Renal Dialysis (Hemodialysis) 01/2019 - 11/2006
3	Steam Bath (Sauna) 04/2007 - 12/2004
2	Transcatheter Aortic Valve Replacement 10/2018 - 11/2010
2	Peritoneal Dialysis 11/2016 - 04/2010
2	Transjugular Intrahepatic Portasystemic Shunt 01/2014 - 01/2003
2	Ligation 10/2011 - 03/2006
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 08/2021
1	Catheters 12/2019
1	Traction 01/2019
1	Secondary Prevention 01/2017